Your browser doesn't support javascript.
loading
Machine Learning for Predicting Mortality in Transcatheter Aortic Valve Implantation: An Inter-Center Cross Validation Study.
Mamprin, Marco; Lopes, Ricardo R; Zelis, Jo M; Tonino, Pim A L; van Mourik, Martijn S; Vis, Marije M; Zinger, Svitlana; de Mol, Bas A J M; de With, Peter H N.
Afiliación
  • Mamprin M; Department of Electrical Engineering, Eindhoven University of Technology, 5612 AE Eindhoven, The Netherlands.
  • Lopes RR; Department of Biomedical Engineering and Physics, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Zelis JM; Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Tonino PAL; Department of Cardiology, Catharina Hospital, 5623 EJ Eindhoven, The Netherlands.
  • van Mourik MS; Department of Cardiology, Catharina Hospital, 5623 EJ Eindhoven, The Netherlands.
  • Vis MM; Heart Centre, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Zinger S; Heart Centre, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • de Mol BAJM; Department of Electrical Engineering, Eindhoven University of Technology, 5612 AE Eindhoven, The Netherlands.
  • de With PHN; Heart Centre, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
J Cardiovasc Dev Dis ; 8(6)2021 Jun 04.
Article en En | MEDLINE | ID: mdl-34199892
ABSTRACT
Current prognostic risk scores for transcatheter aortic valve implantation (TAVI) do not benefit yet from modern machine learning techniques, which can improve risk stratification of one-year mortality of patients before TAVI. Despite the advancement of machine learning in healthcare, data sharing regulations are very strict and typically prevent exchanging patient data, without the involvement of ethical committees. A very robust validation approach, including 1300 and 631 patients per center, was performed to validate a machine learning model of one center at the other external center with their data, in a mutual fashion. This was achieved without any data exchange but solely by exchanging the models and the data processing pipelines. A dedicated exchange protocol was designed to evaluate and quantify the model's robustness on the data of the external center. Models developed with the larger dataset offered similar or higher prediction accuracy on the external validation. Logistic regression, random forest and CatBoost lead to areas under curve of the ROC of 0.65, 0.67 and 0.65 for the internal validation and of 0.62, 0.66, 0.68 for the external validation, respectively. We propose a scalable exchange protocol which can be further extended on other TAVI centers, but more generally to any other clinical scenario, that could benefit from this validation approach.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Cardiovasc Dev Dis Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Cardiovasc Dev Dis Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos